| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/28/2023 | 4.63% | B. Riley Securities | → $21 | Initiates Coverage On | → Buy |
| 05/15/2023 | 4.63% | RBC Capital | → $21 | Reiterates | Sector Perform → Sector Perform |
| 05/09/2023 | -7.82% | Wells Fargo | $17.75 → $18.5 | Maintains | Equal-Weight |
| 05/08/2023 | 4.63% | Truist Securities | $20 → $21 | Maintains | Hold |
| 05/08/2023 | 4.63% | Oppenheimer | → $21 | Reiterates | → Perform |
| 04/18/2023 | -11.56% | Wells Fargo | $19 → $17.75 | Maintains | Equal-Weight |
| 04/12/2023 | 4.63% | Oppenheimer | → $21 | Initiates Coverage On | → Perform |
| 03/01/2023 | 7.13% | Keefe, Bruyette & Woods | $21 → $21.5 | Maintains | Market Perform |
| 03/01/2023 | -5.33% | Wells Fargo | $18.5 → $19 | Maintains | Equal-Weight |
| 11/10/2022 | 4.63% | RBC Capital | $23 → $21 | Maintains | Sector Perform |
| 11/09/2022 | -7.82% | Wells Fargo | $18 → $18.5 | Maintains | Equal-Weight |
| 10/24/2022 | -10.31% | Wells Fargo | $20.5 → $18 | Maintains | Equal-Weight |
| 08/10/2022 | 14.6% | RBC Capital | $24 → $23 | Maintains | Sector Perform |
| 08/10/2022 | 2.14% | Wells Fargo | $19 → $20.5 | Maintains | Equal-Weight |
| 05/11/2022 | -2.84% | Wells Fargo | $21 → $19.5 | Maintains | Equal-Weight |
| 04/25/2022 | 4.63% | Wells Fargo | $21.5 → $21 | Maintains | Equal-Weight |
| 03/02/2022 | 7.13% | Wells Fargo | $19.5 → $21.5 | Upgrades | Underweight → Equal-Weight |
| 10/25/2021 | -5.33% | Wells Fargo | $22 → $19 | Maintains | Underweight |
| 06/18/2021 | 14.6% | RBC Capital | → $23 | Initiates Coverage On | → Sector Perform |
| 12/07/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 11/12/2020 | — | Wells Fargo | Downgrades | Equal-Weight → Underweight | |
| 09/23/2020 | -20.28% | Truist Securities | → $16 | Initiates Coverage On | → Hold |
| 08/13/2020 | -22.77% | Wells Fargo | $14 → $15.5 | Maintains | Equal-Weight |
| 08/11/2020 | -17.79% | Compass Point | → $16.5 | Downgrades | Buy → Neutral |
| 08/03/2020 | -25.26% | JP Morgan | → $15 | Downgrades | Overweight → Neutral |
| 06/24/2020 | -15.3% | Raymond James | → $17 | Upgrades | Market Perform → Outperform |
| 06/18/2020 | -30.24% | Wells Fargo | → $14 | Initiates Coverage On | → Underweight |
| 05/08/2020 | -81.32% | Keefe, Bruyette & Woods | $4 → $3.75 | Maintains | Market Perform |
| 03/25/2020 | -80.07% | Wells Fargo | $6.25 → $4 | Maintains | Equal-Weight |
| 10/10/2019 | -60.14% | Jefferies | → $8 | Initiates Coverage On | → Buy |
| 08/09/2019 | -67.61% | JP Morgan | → $6.5 | Upgrades | Neutral → Overweight |
| 06/05/2019 | — | Raymond James | Initiates Coverage On | → Market Perform |
What is the target price for FS KKR Capital (FSK)?
The latest price target for FS KKR Capital (NYSE: FSK) was reported by B. Riley Securities on July 28, 2023. The analyst firm set a price target for $21.00 expecting FSK to rise to within 12 months (a possible 4.63% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for FS KKR Capital (FSK)?
The latest analyst rating for FS KKR Capital (NYSE: FSK) was provided by B. Riley Securities, and FS KKR Capital initiated their buy rating.
When is the next analyst rating going to be posted or updated for FS KKR Capital (FSK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FS KKR Capital, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FS KKR Capital was filed on July 28, 2023 so you should expect the next rating to be made available sometime around July 28, 2024.
Is the Analyst Rating FS KKR Capital (FSK) correct?
While ratings are subjective and will change, the latest FS KKR Capital (FSK) rating was a initiated with a price target of $0.00 to $21.00. The current price FS KKR Capital (FSK) is trading at is $20.07, which is within the analyst's predicted range.